Journey Medical Corp. (DERM)
7.59
-0.32
(-4.05%)
USD |
NASDAQ |
Aug 25, 14:33
Journey Medical Total Liabilities (Quarterly) : 66.24M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 66.24M |
| March 31, 2026 | 60.70M |
| December 31, 2025 | 62.74M |
| September 30, 2025 | 59.29M |
| June 30, 2025 | 61.91M |
| March 31, 2025 | 63.42M |
| December 31, 2024 | 60.17M |
| September 30, 2024 | 53.12M |
| June 30, 2024 | 53.89M |
| March 31, 2024 | 53.62M |
| December 31, 2023 | 56.50M |
| September 30, 2023 | 48.54M |
| Date | Value |
|---|---|
| June 30, 2023 | 69.74M |
| March 31, 2023 | 88.36M |
| December 31, 2022 | 88.18M |
| September 30, 2022 | 81.96M |
| June 30, 2022 | 78.70M |
| March 31, 2022 | 79.46M |
| December 31, 2021 | 55.24M |
| September 30, 2021 | 100.77M |
| June 30, 2021 | 73.52M |
| March 31, 2021 | |
| December 31, 2020 | 41.61M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Nektar Therapeutics | 192.01M |
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 182.93M |
| Veru, Inc. | 8.651M |
| Johnson & Johnson | 116.09B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 98.36M |
| Shareholders Equity (Quarterly) | 32.11M |
| Debt to Equity Ratio | 0.7953 |
| Current Ratio | 1.590 |
| Net Debt Paydown Yield | -0.04% |